Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

PubMed

Regulatory Framework for Implantable Neurostimulation Devices: Comparison of Systems in the US and European Union.

PMID: 37306642 ·

A, n, d, r, e, a, s, , A, m, o, n, ;, , T, i, m, o, t, h, y, , M, a, r, j, e, n, i, n, ;, , R, u, i, , V, , D, u, a, r, t, e, ;, , C, h, r, i, s, t, o, p, h, e, r, , G, i, l, l, i, g, a, n, ;, , S, i, m, o, n, , J, a, m, e, s, , T, h, o, m, s, o, n, ;, , S, a, m, , E, l, d, a, b, e, ;, , F, r, a, n, ç, o, i, s, , A, l, e, s, c, h

RevistaNeuromodulation : journal of the International Neuromodulation Society
Ano
PMID37306642

Resumo

Implantable neurostimulation devices must be authorized before they are placed on the market. For this purpose, requirements, and processes for assessing their fulfillment, have been defined in different jurisdictions. In this study, we aimed to address differences between the US and European Union (EU) regulatory systems and their relationship to innovation. A literature review and analysis were conducted using legal texts and guidance documents. The US system has one central body, the Food and

Fonte oficial

Ver no PubMed →

Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.

↑